Clock.Bio

clock.health | Home

Cambridge, United Kingdom · Founded 2023 · $5.3M raised

Headquarters
Cambridge
Employees
1–10
Founded
2023
Business Model
B2B
Total Funding
$5.3M
Last Round
$5.3M SeedOct 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

clock.bio is a rejuvenation biology company developing therapies to extend human healthspan by reversing cellular aging at the genetic level. Using proprietary CRISPR screens in human induced pluripotent stem cells, the company has mapped over 150 genes in its 'geneAge Atlas of Rejuvenation Factors' and built an AI-powered cell age measurement platform called imAge. Based at the Milner Therapeutics Institute, University of Cambridge, the company raised $5.3M in seed funding in 2024.

Summary

Clock.Bio is a Biotech company based in Cambridge, United Kingdom, founded in 2023. It has raised $5.3M in total across 1 round, most recently a $5.3M Seed round in Oct 2024. Investors include LocalGlobe and BlueYard Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundOct 2024
$5.3M

Investors

Similar Companies

LifeMine

Therapeutics company working in drug discovery and development using fungi with genomics approach...

Watertown, United States51–200Biotech, Drug Discovery
Venture RoundTotal funding$816.0MAug 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
PacBioIPO

Developer and manufacturer of high-accuracy long-read DNA sequencing systems and consumables for ...

USA, United States501–1000Biotech, Genomics
ConvertibleTotal funding$1.2BFeb 2021
Element Biosciences

Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...

San Diego, United States201–500Biotech, Genomics
Series ETotal funding$853.3MJun 2026
Treeline Biosciences

Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...

Watertown, United States51–200Biotech, Drug Discovery
Extension RoundTotal funding$821.8MSep 2025
Tessera Therapeutics

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Somerville, United States201–500Biotech, Genomics
Corporate RoundTotal funding$730.0MDec 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Clock.Bio on Indexed.vc
<a href="https://indexed.vc/companies/clock-bio"><img src="https://indexed.vc/api/badge/company/clock-bio" alt="Clock.Bio on Indexed.vc" width="260" height="76" /></a>